ORMP

#3277
Oramed Pharmaceuticals Inc. - Common Stock
3.9 7 USD
+0.25%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
3.97
3.97
Year Range
1.98
5.01
Daily Change
+0.25%
Monthly Change
+2.85%
6 month change
+41.79%
Year Change
+74.89%
Previous Close
3.9 6
Open
3.9 7
Low
3.9 7
High
3.9 7
Volume
8
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 162.48 M
  • Employee 13
  • Founded 2006
  • CEO Nadav Kidron
  • Website www.oramed.com
  • Headquarter Delaware, United States
  • FIGI BBG000LRYR36
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
1.9
Price to sales ratio
60.45
Dividends per share
0.25
Dividend yield %
8.77

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

News